Advertisement
Taking Action

Advocacy

  • Taking Answers Home

    Advocates bring the patient perspective to the AACR Annual Meeting 2024 and leave with tools to better communicate advances in care to others.

    by Eric Fitzsimmons

  • Policy Matters

    Cancer Research Funding Faces Uncertain Future

    The AACR is planning numerous initiatives in 2024 to bolster congressional support.

    by Jon Retzlaff, MBA, MPA

  • Policy Matters

    Taking Action to Support Cancer Research

    The AACR releases AACR Cancer Progress Report 2023, announces Cancer Centers Alliance, and joins 11th Rally for Medical Research.

    by Benjamin Krinsky, PhD

  • Progress in Rare Cancers

    With the rise of patient-driven research and registries, scientists are making advances in understanding, diagnosing and treating many of the least common cancer types.

    by Kendall K. Morgan

  • Patient Advocates as Research Partners

    Speakers at SABCS discuss how people who have lived with breast cancer can be valuable partners in research.

    by Eric Fitzsimmons

  • Accelerating and Improving Drug Discovery

    Forum for patient advocates explores how researchers are working to develop cancer treatments in a quicker, more efficient manner.

    by Thomas Celona

  • Making Clinical Trials Easier

    Clinical trials can be hard to find, challenging to get into and difficult to complete. Patient advocates and their supporters want to change that.

    by Cameron Walker

  • Policy Matters

    Reigniting the Moonshot

    President Biden proposes increased investment in cancer research and prevention to achieve the goals of the revised Cancer Moonshot.

    by Roy S. Herbst, MD, PhD

  • Building Bridges

    AACR Scientist↔Survivor Program celebrates 25 years of sparking conversations between cancer patients and researchers.

    by Thomas Celona

  • Policy Matters

    Early-career Cancer Researchers Return to Washington

    AACR Early-career Hill Day allows associate members to visit Capitol Hill and advocate for medical research funding.

    by Matt Gontarchick